Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related ABT
Top Performing Industries For June 16, 2015
Mylan Offers Response to Abbott's Support for Perrigo Deal
Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog (Zacks)
Related PCLN
Priceline Still A Buy And Worth $1,360/Share, Cantor Reiterates
What These Pundits Said Will Make You Want To Hoard Cash
The Vetr community has upgraded $PCLN to 4.5-Stars. (Vetr)

Analysts at Goldman Sachs upgraded Abbott Laboratories (NYSE: ABT) from “neutral” to “buy.” The target price for Abbott Laboratories has been raised from $38 to $44. Abbott's stock closed at $36.59 on Friday.

Deutsche Bank upgraded priceline.com (NASDAQ: PCLN) from “hold” to “buy.” The target price for priceline.com has been raised from $715 to $900. priceline.com's shares closed at $813.66 on Friday.

Analysts at Maxim Group upgraded J.C. Penney Company (NYSE: JCP) from “hold” to “buy.” The target price for J.C. Penney has been raised from $16.50 to $27. J.C. Penney's shares closed at $18.01 on Friday.

Morgan Stanley upgraded E-Commerce China Dangdang (NYSE: DANG) from “equal-weight” to “overweight.” The target price for E-Commerce China Dangdang has been raised from $5 to $6.50. E-Commerce China Dangdang's shares closed at $5.71 on Friday.

Latest Ratings for ABT

DateFirmActionFromTo
Jun 2015BTIG ResearchInitiates Coverage onBuy
May 2015Evercore PartnersInitiates Coverage onBuy
May 2015Evercore ISIInitiates Coverage onBuy

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ABT + DANG)

Around the Web, We're Loving...

Get Benzinga's Newsletters